Emerging of the first NOVEL CANADIAN ADJUVANT and its potential in vaccine development and immunotherapy

H1N1 Flu Virus Sudbury & District Health Unit Response. Shelley Westhaver May 2009

H1N1 Flu Virus Sudbury & District Health Unit Response Shelley Westhaver May 2009 Pandemic Influenza A global outbreak of disease that occurs when a new influenza virus appears or emerges in the human

Management of Pandemic Influenza Outbreaks. Bryan K Breland Director, Emergency Management University of Alabama at Birmingham

Management of Pandemic Influenza Outbreaks Bryan K Breland Director, Emergency Management University of Alabama at Birmingham Management of Pandemic Disease Outbreaks PANDEMIC DEFINED HISTORY OF PANDEMIC

Influenza & Other Modelling Activities at the Public Health Agency of Canada (PHAC)

Influenza & Other Modelling Activities at the Public Health Agency of Canada (PHAC) Teresa Mersereau and Dena Schanzer, Public Health Agency of Canada Pan-InfORM and NCCID Co-hosted Workshop: Use of Mathematical

WHO Response to Influenza A (H1N1) CAPSCA December, 2011 Dr. Nasr Eltantawy Medical epidemiologist WHO/Egypt

WHO Response to Influenza A (H1N1) 2009 CAPSCA 11-14 December, 2011 Dr. Nasr Eltantawy Medical epidemiologist WHO/Egypt Outline Background. Preparedness planning. Evolution of the pandemic. WHO and other

DRAFT WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE.

What Can I Do As A National Leader? This publication was produced by the AI.COMM project, managed by the Academy for Educational Development (AED), and funded by the U.S. Agency for International Development

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

University of Colorado Denver Pandemic Preparedness and Response Plan April 30, 2009 UCD Pandemic Preparedness and Response Plan Executive Summary The World Health Organization (WHO) and the Centers for

Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect

PANDEMIC INFLUENZA IN THE WORKPLACE

PANDEMIC INFLUENZA IN THE WORKPLACE 1 WILLIAM CANDLER, D.O., M.T.M.& H. Medical Director John Deere Harvester Works, Seeding Group and Cylinder Division Proposed Crisis Management Structure CORPORATE CRISIS

Pandemic Influenza Preparedness. Vaccine Sharing. Robert Gatter Center for Health Law Studies

Pandemic Influenza Preparedness and the Global Stalemate over Vaccine Sharing Robert Gatter Center for Health Law Studies Saint Louis University GISN and Indonesia sprotests WHO member states share flu

Dynavax Corporate Presentation

Dynavax Corporate Presentation Forward-Looking Statements This presentation contains forward-looking statements, including statements regarding our HEPLISAV-B TM regulatory submissions, product profile,

Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare

Epidemiology Treatment and control Sniffles and Sneezes Mortality Spanish flu Asian flu Hong Kong flu The Swine flu scare Epidemiology The Flu Virus Influenza is commonly called the flu. The most deadly

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Masaya Kato, WHO Viet Nam OIE Regional Workshop on Enhancing Influenza A viruses National Surveillance

Approaches to Pandemic Influenza Vaccine Preparedness

United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Approaches to Pandemic Influenza Vaccine Preparedness Julie Schafer, MPH, MS Influenza

The Impact of Pandemic Influenza on Public Health

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

An Affordable Pandemic Influenza Vaccine Solution for Developing Countries (and Developed Countries Too)

An Affordable Pandemic Influenza Vaccine Solution for Developing Countries (and Developed Countries Too) James M. Robinson, PE VP Technical and Quality Operations Novavax, Inc. New Cells for New Vaccines

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)

Influenza: The Threat of a Pandemic

April, 2009 Definitions Epidemic: An increase in disease above what you what would normally expect. Pandemic: A worldwide epidemic 2 What is Influenza? Also called Flu, it is a contagious respiratory illness

GOVERNMENT OF ALBERTA. Alberta s Plan for Pandemic Influenza

GOVERNMENT OF ALBERTA Alberta s Plan for Pandemic Influenza November 2003 What is pandemic influenza? The word pandemic is used to describe diseases that cause worldwide outbreaks of illness involving

Avian Influenza (Bird Flu) Fact Sheet

What is an avian influenza A (H5N1) virus? Influenza A (H5N1) virus also called H5N1 virus is an influenza A virus subtype that occurs mainly in birds. It was first isolated from birds (terns) in South

Pandemic Influenza Preparedness and Response

24 th Meeting of Ministers of Health Dhaka, Bangladesh, 20-21 August 2006 SEA/HMM/Meet.24/4(b) 10 July 2006 Pandemic Influenza Preparedness and Response Regional situation: Human cases and outbreaks of

PANDEMIC INFLUENZA PREPAREDNESS: STATE CHALLENGES

PANDEMIC INFLUENZA PREPAREDNESS: STATE CHALLENGES A Presentation to the Council of State Governments Health Policy Forum by Jeffrey Levi, Ph.D., Executive Director Trust for America s Health June 23, 2006

U.S. Readiness for Pandemics

0 U.S. Readiness for Pandemics 5 th National Emergency Management Summit Brooklyn, NY September 15, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary for Preparedness & Response (HHS/ASPR) Director

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme

Global Challenges of Pandemic and Avian Influenza 19 December 2006 Keiji Fukuda Global influenza Programme Summary of Current H5N1 Situation 1997 First known outbreak infecting humans 18 people hospitalized

H1N1 influenza pandemic ( Spanish flu ) probably killed million people globally. Seasonal flu can cause ,000 deaths (WHO).

Influenza-1918-2018. Are we ready for another pandemic? 1918-20 H1N1 influenza pandemic ( Spanish flu ) probably killed 50-100 million people globally. Seasonal flu can cause 250-500,000 deaths (WHO).

Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak

Johor Bahru Health Office Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak Dr. Badrul Hisham bin Abd. Samad MBBS (Malaya), MPH (Glasgow), M. Environmental Engineering (UTM),

Caribbean Actuarial Association

Caribbean Actuarial Association Pandemic Coverage Presented by Annemarie Brownmiller Consulting Services of Princeton, LLC atbrownmiller@comcast.net D. Grenville MacDonald Park Re Canada gmacdonald@parkrecanada.com

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell

Prepare to Care Pandemic Planning at Fraser Health

Prepare to Care Pandemic Planning at Fraser Health Pandemic Influenza Planning December 10, 2009 Facilitator: Lisa Zetes-Zanatta 7 Prepare to Care: Introductions FHA Pandemic Lady Lisa Zetes-Zanatta Roundtable

Plant-Derived Influenza Virus-Like Particles: A Unique Combination of Highly Effective Product and Cost-Effective Manufacturing

Plant-Derived Influenza Virus-Like Particles: A Unique Combination of Highly Effective Product and Cost-Effective Manufacturing Nathalie Charland, PhD GHSI Workshop on Public Health Emergency Medical Countermeasures

GSK commitment to influenza prevention

GSK commitment to influenza prevention Dr Catia Ferreira Influenza Portfolio US Medical Affairs Leader GSK Vaccines GSK commitment to Influenza Rixensart (Belgium) Shenzhen (China) Marietta (US) Saint-Amand

Devon Community Resilience. Influenza Pandemics. Richard Clarke Emergency Preparedness Manager Public Health England South West Centre

Devon Community Resilience Influenza Pandemics Richard Clarke Emergency Preparedness Manager Public Health England South West Centre What is a pandemic? 2 Devon Community Resilience - Influenza Pandemics

Before and during influenza pandemics

before and during influenza pandemics Klaus Stöhr Department for Communicable Diseases Surveillance and Response Before and during influenza pandemics Before pandemics: interpandemic period New human influenza

ORTHOMYXOVIRUSES INFLUENZA VIRUSES. (A,B and C)

ORTHOMYXOVIRUSES INFLUENZA VIRUSES (A,B and C) Orthomyxoviridae Influenza Viruses Epidemiology: Influenza A virus is so subjected to major antigenic changes that cause occasional world wide pandemics when

GSK s Adjuvanted Influenza Vaccines The Taming of the Flu

GSK s Adjuvanted Influenza Vaccines The Taming of the Flu JITMM, Bangkok, October 2008 Bruce L. Innis, MD Global Clinical Research and Development GlaxoSmithKline Biologicals 1 Annual Burden of Influenza

There are no financial implications arising from this report.

STAFF REPORT INFORMATION ONLY Pandemic Influenza Preparedness Update Date: March 22, 2007 To: From: Wards: Board of Health Medical Officer of Health All Reference Number: SUMMARY This report updates the

Industry Perspective: Strategies and costs associated with increasing seasonal influenza vaccine. since 2006

Industry Perspective: Strategies and costs associated with increasing seasonal influenza vaccine use from high to low income countries since 2006 Dr. Michael Watson, sanofi-pasteur on behalf of WHO GAP

A/H1N influenza in Israel: Preparedness and response

A/H1N1 2009 influenza in Israel: Preparedness and response Prof. Itamar Grotto MD, MPH, PhD Director, Public Health Services Israel Ministry of Health Science Policy Preparedness Previous influenza pandemics

Public Health Preparedness and Response Update

Public Health Preparedness and Response Update August 3 rd, 2010 San Francisco Department of Public Health Office of Policy and Planning Preparedness Vision Vision The San Francisco Department of Public

TABLE OF CONTENTS. Peterborough County-City Health Unit Pandemic Influenza Plan Section 1: Introduction

TABLE OF CONTENTS 1. Introduction...1-2 1.1 Background...1-2 1.2 Why Does Peterborough County and City Need a Plan for Influenza Pandemic?...1-2 1.3 About Influenza...1-3 1.4 When Does Influenza Become

Vaccine Innovation and Adult Immunization Landscape

Vaccine Innovation and Adult Immunization Landscape National Adult and Influenza Immunization Summit, May 12-14, 2015 Phyllis Arthur Senior Director Vaccines, Immunotherapeutics & Diagnostics Policy parthur@bio.org

7th Mena Influenza Stakeholders Meeting. WHO Influenza Strategy Development and Vaccine-related Research Priorities

7th Mena Influenza Stakeholders Meeting WHO Influenza Strategy Development and Vaccine-related Research Priorities Wenqing Zhang 9 10 September 2017 Riga, Latvia 1 Seasonal influenza 1 billion cases yearly

Stockpiling of H5N1 vaccines

Stockpiling of H5N1 vaccines Norbert W. Hehme EVM Influenza Pandemic Working Group EU-Commission Workshop on Stockpiling of Medicinal Products February 21/22, 2008 European Vaccine Manufacturers 1 (EVM)

Michel BAIJOT Vice President, WW Business Development & Strategic Alliances

Technology Transfer and Vaccines: The GSK Experience WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Geneva, November 30th, 2010 Michel BAIJOT Vice President, WW Business

SHOULD THE US DEVELOP AND STOCKPILE VACCINES AGAINST A(H5N1) When first reading this question, one s instinct is of course to say yes!

Kathleen Tait Biology 501 July 7, 2006 SHOULD THE US DEVELOP AND STOCKPILE VACCINES AGAINST A(H5N1) AVIAN FLU? When first reading this question, one s instinct is of course to say yes! This would be a

Pandemic Preparedness: People, Plans, Products, and Practice. Julie Louise Gerberding, MD, MPH

Pandemic Preparedness: People, Plans, Products, and Practice Julie Louise Gerberding, MD, MPH The Burden of Influenza Seasonal Influenza Globally: 250,000 to 500,000 deaths each year In the United States

SWINE FLU 3: NOW NAMED H1N1 INFLUENZA A

1 Created by LifeWind International SWINE FLU 3: NOW NAMED H1N1 INFLUENZA A Date: 5/09 (1 HOUR) OBJECTIVES: After working through this lesson, participants will be able to: 1. Explain how swine flu spreads

Pandemic Preparedness: Pigs, Poultry, and People versus Plans, Products, and Practice

SUPPLEMENT ARTICLE Pandemic Preparedness: Pigs, Poultry, and People versus Plans, Products, and Practice Julie L. Gerberding Centers for Disease Control and Prevention, Atlanta, Georgia Influenza pandemic

Pandemic Influenza Cross Sectoral Preparedness and Planning

Opening statement Seminar on Pandemic Influenza Cross Sectoral Preparedness and Planning Ministry of Health and Care Services, Oslo 19. February 2009 State secretary Rigmor Aasrud Dear speakers, dear participants,

8. Public Health Measures

8. Public health measures are actions taken to prevent, control or mitigate the effects of a pandemic. These decisions will range from population based recommendations to individual measures. The type

Best Practice Guideline for the Workplace During Pandemic Influenza OHS & ES

Best Practice Guideline for the Workplace During Pandemic Influenza OHS & ES May/June 2009 Karlene Johner Laura Geddert Alberta Employment and Immigration Outline Document final May 2009 What is pandemic

INFLUENZA PANDEMIC CONTINUED FOCUS ON THE NATION S PLANNING AND PREPAREDNESS EFFORTS REMAINS ESSENTIAL

INFLUENZA PANDEMIC CONTINUED FOCUS ON THE NATION S PLANNING AND PREPAREDNESS EFFORTS REMAINS ESSENTIAL page 1 / 5 page 2 / 5 influenza pandemic continued focus pdf The 2009 flu pandemic or swine flu was

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States

WHOLE OF - SOCIETY PANDEMIC READINESS

WHOLE OF - SOCIETY PANDEMIC READINESS May 7, 2009 9AM Nairobi, Kenya Dr Liviu Vedrasco vedrasco@un.org Pandemic Influenza Coordination Team (PIC) UN Office for the Coordination of Humanitarian Affairs

Public Safety and Health Cooperation from the Canadian Perspective

1 2 Public Safety and Health Cooperation from the Canadian Perspective Presentation by: Dr. Rainer Engelhardt Assistant Deputy Minister Infectious Disease Prevention and Control Public Health Agency of

Towards a Sustainable Global Infrastructure for Medical Countermeasures

Towards a Sustainable Global Infrastructure for Medical Countermeasures Institute of Medicine The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from

PANDEMIC INFLUENZA: CURRENT THREAT AND CALL FOR ACTION. Kirsty Duncan PhD FSAScot

PANDEMIC INFLUENZA: CURRENT THREAT AND CALL FOR ACTION Kirsty Duncan PhD FSAScot NEW INFLUENZA VIRUS, NEW THREAT NEW STRAIN OF FLU COULD KILL MILLIONS AROUND THE WORLD WORLD IS NOT READY FOR A FLU PANDEMIC

Should the US develop and Stockpile Vaccines and Antiviral Medications Against. A(H5N1) Avian Flu?

Spring Upshaw Biology Due: 7/7/06 Should the US develop and Stockpile Vaccines and Antiviral Medications Against A(H5N1) Avian Flu? The A(H5N1) avian flu, which has existed since 1997 is lethal in humans

TAKEDA VACCINES INNOVATION FOR GLOBAL IMPACT. RAJEEV VENKAYYA, MD President, Global Vaccine Business Unit

TAKEDA VACCINES INNOVATION FOR GLOBAL IMPACT RAJEEV VENKAYYA, MD President, Global Vaccine Business Unit OUR MISSION Develop and deliver innovative vaccines that tackle the toughest problems in public

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments

Public Health Emergencies: Volunteer Recruitment

Public Health Emergencies: Volunteer Recruitment Purpose To provide an overview of the Cook County Department of Public Health s (CCDPH) role and your municipality s role in planning and responding to

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response

Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response York County Pandemic Influenza Stakeholders Village by the Sea, Wells, Maine 8 August 2006 Steven J Trockman,

Emerging Infections: Pandemic Influenza. W. Paul Glezen

Emerging Infections: Pandemic Influenza W. Paul Glezen Challenges The trends of modern society tend to facilitate spread and increase morbidity Travel, urbanization morbidity vs. mortality The cost of

Influenza Pandemic Preparedness for Clinicians on the Frontline

Influenza Pandemic Preparedness for Clinicians on the Frontline CAPT HA C. TANG, DO US Public Health Service Adjunct Associate Clinical Professor of Dartmouth Medical School, Community/Family Medicine

Financing Influenza Vaccine R&D

Financing Influenza Vaccine R&D WHO GAP-II Geneve, Switzerland July 13, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary & Director HHS/ASPR/BARDA 0 Vaccine Development is Risky, Lengthy, & Expensive

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC?

Cambridge Judge Business School Centre for Risk Studies IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC? Dr Andrew Coburn Chief Scientist Cambridge Centre for Risk Studies 5 December

Countries initially targeted: Bangladesh, Mongolia, Myanmar, Nepal, Lao People s Demoncratic Republic and Pakistan.

PUI PROJECT PROPOSAL ON BUILDING AND IMPROVEMENT OF ANIMAL DISEASE DIAGNOSTIC CAPACITIES OF VETERINARY LABORATORIES IN ASIA BY TRANSFER OF NUCLEAR AND NUCLEAR RELATED TECHNIQUES: A REGIONAL APPROACH FOR

INFLUENZA-2 Avian Influenza

INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature

Conflict of Interest and Disclosures. Research funding from GSK, Biofire

Pandemic Influenza Suchitra Rao, MBBS, Assistant Professor, Pediatric Infectious Diseases, Hospital Medicine and Epidemiology Global Health and Disasters Course, 2018 Conflict of Interest and Disclosures

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

County-Wide Pandemic Influenza Preparedness & Response Plan

County-Wide Pandemic Influenza Preparedness & Response Plan Presented by the Santa Clara County Public Health Department to the Emergency Managers Association April 27, 2006 Why the Concern About Pandemic

The H5N1 case: A virologist s view

The H5N1 case: A virologist s view Jan Wilschut Department of Molecular Virology University Medical Center Groningen Groningen, The Netherlands Meeting of States Parties - Side Event Geneva, 11 December

PANDEMIC INFLUENZA PLAN

PANDEMIC INFLUENZA PLAN August 13, 2009 Credits: We wish to acknowledge and thank Saskatoon Public Schools for their willingness to share information which served as the basis for this document. 1 Pandemic

Transforming The Approach to Vaccines and Protein- Based Therapeutics. Alain Doucet, Ph.D. Manager, Process Development, Medicago

Transforming The Approach to Vaccines and Protein- Based Therapeutics Alain Doucet, Ph.D. Manager, Process Development, Medicago 2018-08-15 1 Medicago Overview 2 Novel Technologies 3 Robust Pipeline 2

BioDiem to present at Hong Kong biotech investment forum

ASX Announcement BIODIEM LTD ABN 20 096 845 993 Suite 3, Level 11, 470 Collins Street, Melbourne, Victoria, 3000 Australia Phone: +613 9613 4100 Web: www.biodiem.com BioDiem to present at Hong Kong biotech

EVOLUTION: WHY DOES IT MATTER? What did evolution ever do for me?

EVOLUTION: WHY DOES IT MATTER? What did evolution ever do for me? www.christs.cam.ac.uk/darwin200 Evolution is change in living things through descent with modification Evolution is change in living things

Global Health Security: Preparedness and Response: can we do better and stay safe?

Global Health Security: Preparedness and Response: can we do better and stay safe? John Watson Health Protection Directorate, Public Health England Formerly Deputy Chief Medical Officer, Department of

Influenza vaccine-it s complicated. Mark H. Sawyer MD UCSD School of Medicine and Rady Children s Hospital San Diego

Influenza vaccine-it s complicated Mark H. Sawyer MD UCSD School of Medicine and Rady Children s Hospital San Diego Objectives Explain how new strains of influenza virus are created so that you understand

Influenza: A Challenge?

Short Communication (Expert Talk) ISSN:2394-2371 CODEN (USA):IJPTIL Influenza: A Challenge? Dr. A K Prasad Founder Chairman / President, Influenza Foundation (India) E.Mail: anilkpd2004@yahoo.com ABSTRACT

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

TheSentinel. Reporting on Preparedness. District 2 Public Health (North) Emergency Preparedness Gainesville, Georgia. July 2009 Volume 7 Issue 4

TheSentinel Reporting on Preparedness District 2 Public Health (North) Emergency Preparedness Gainesville, Georgia July 2009 Volume 7 Issue 4 Influenza Pandemic 1 Steps toward a vaccine 1 News Briefs 3

Pandemic Influenza Planning:

Pandemic Influenza Planning: Get Information. Stay Informed. U.S. Department of Health and Human Services May 2006 While the Federal Government will use all resources at its disposal to prepare for and

4.3.9 Pandemic Disease

4.3.9 Pandemic Disease This section describes the location and extent, range of magnitude, past occurrence, future occurrence, and vulnerability assessment for the pandemic disease hazard for Armstrong

Medicago: transforming the approach to vaccines and protein-based therapeutics. Bruce D. Clark PhD President & CEO September 27, 2017

Medicago: transforming the approach to vaccines and protein-based therapeutics Bruce D. Clark PhD President & CEO September 27, 2017 Medicago Overview Focus Manufacturing technology Vaccine technology

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks

2009 (Pandemic) H1N1 Influenza Virus

2009 (Pandemic) H1N1 Influenza Virus September 15, 2009 Olympia, Washington Anthony A Marfin Washington State Department of Health Goals Understand current situation & pattern of transmission of 2009 H1N1

Management Presentation. January 2019

Management Presentation January 2019 Forward Looking Statements The statements made in this presentation may include forward-looking statements regarding the treatment of smallpox and other orthopoxvirusinfections,

H1N1 Response and Vaccination Campaign

2009-2010 H1N1 Response and Vaccination Campaign Stephanie A. Dopson, MSW, MPH, ScD. Candidate Influenza Coordination Unit Centers for Disease Control and Prevention CDC H1N1 Response In late March and

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals Jefferies 2010 Global Life Sciences Conference New York Stuart Grant Senior Vice President & Chief Financial Officer Rob Bennett Executive Director, Investor Relations & Business

Should the U.S. develop and stockpile vaccines against A(H5N1) avian flu?

Amy Dewees July 7, 2006 Biol 501 Should the U.S. develop and stockpile vaccines against A(H5N1) avian flu? A(H5N1) is a strain of flu virus that infects many species of birds, including domestic and migratory

Health Task Force Workplan

2006/SOM 3/HTF/021 Agenda Item: VI Health Task Force Workplan 2006-2007 Purpose: Information Submitted by: Chair Health Task Force Meeting Da Nang, Viet Nam 14 15 September 2006 APEC HEALTH TASK FORCE

Core Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning

Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning

Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning APHA Annual Meeting San Francisco, California Lara Misegades, MS Director of Infectious Disease Policy November 18, 2003 Overview

Influenza Virus: Evolution of a Deadly Virus in our World

Influenza Virus: Evolution of a Deadly Virus in our World Cathy M. St. Pierre, PhD, APRN, FNP-BC, FAANP ENRM. VA HOSPITAL Bedford, Massachusetts, USA ACKNOWLEDGEMENT THIS AUTHOR WOULD LIKE TO GRATEFULLY

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Virus Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H), neuraminidase (N) A H3N2,

What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer and Medical Director of Communicable Disease Control

Vancouver Coastal Health & The Vancouver Coastal Health Research Institute presents: On Call with VGH Experts Lecture Series The Flu and You What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer

Vaccinating Against the Pandemic H1N1 Influenza Virus. Background. Milestones in Influenza Vaccine Development. Increased Safety, Less Reactogenicity

Vaccinating Against the Pandemic H1N1 Influenza Virus Background Alvin Nelson El Amin, MD, MPH Medical Director Immunization Program Milestones in Influenza Vaccine Development Isolation of the influenza

The Vaccine Formulation Laboratory

FIFTH MEETING WITH INTERNATIONAL PARTNERS ON PROSPECTS FOR INFLUENZA VACCINE TECHNOLOGY TRANSFER TO DEVELOPING COUNTRY VACCINE MANUFACTURERS The Vaccine Formulation Laboratory Adjuvant Hub & Training Center

Advancing Pandemic Preparedness through APSED III

Advancing Pandemic Preparedness through APSED III Masaya Kato Programme Area Manager Country Health Emergency Preparedness and the IHR (CPI) WHO Health Emergencies Programme (WHE) WHO Western Pacific Regional

Ralph KY Lee Honorary Secretary HKIOEH

HKIOEH Round Table: Updates on Human Swine Influenza Facts and Strategies on Disease Control & Prevention in Occupational Hygiene Perspectives 9 July 2009 Ralph KY Lee Honorary Secretary HKIOEH 1 Influenza

Pandemic Influenza Preparedness

Pandemic Influenza Preparedness Of the many health threats that we are preparing for, this is the one that we know will happen. Bruce G. Gellin, MD, MPH Director, National Vaccine Program Office Department